相似文献
1
Update on intestinal strictures.
J R Soc Med. 1999;92 Suppl 37(Suppl 37):41-9. doi: 10.1177/014107689909237S08.
2
Colonic strictures in cystic fibrosis.
Lancet. 1994 Mar 12;343(8898):615-6. doi: 10.1016/s0140-6736(94)92629-8.
3
Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis.
Br J Radiol. 1994 Sep;67(801):900-1. doi: 10.1259/0007-1285-67-801-900.
4
Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
Lancet. 1994 Jan 8;343(8889):85-6. doi: 10.1016/s0140-6736(94)90817-6.
5
Colonic strictures in children with cystic fibrosis.
Radiology. 1995 Jan;194(1):223-6. doi: 10.1148/radiology.194.1.7997557.
6
Fibrosing colonopathy in cystic fibrosis.
Arch Dis Child. 1996 May;74(5):464-8. doi: 10.1136/adc.74.5.464.
7
Colonic stricture in a boy with cystic fibrosis.
Postgrad Med J. 1995 May;71(835):309-12. doi: 10.1136/pgmj.71.835.309.
8
Colonic strictures in cystic fibrosis.
Arch Dis Child. 1995 Aug;73(2):184. doi: 10.1136/adc.73.2.184-b.
9
Update on the United States epidemiology study.
Postgrad Med J. 1996 Mar;72 Suppl 2:S6; discussion S7-10.
10
Colonic strictures in cystic fibrosis.
J R Soc Med. 1995;88 Suppl 25(Suppl 25):3-8.
引用本文的文献
1
Genome Editing for Cystic Fibrosis.
Cells. 2023 Jun 6;12(12):1555. doi: 10.3390/cells12121555.
2
Control of malabsorption in cystic fibrosis.
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
本文引用的文献
1
Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.
Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):347-58. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<347::AID-PDS305>3.0.CO;2-2.
2
Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
Pediatr Dev Pathol. 1998 Jan-Feb;1(1):74-8. doi: 10.1007/s100249900009.
3
Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
Arch Dis Child. 1998 Oct;79(4):339-43. doi: 10.1136/adc.79.4.339.
4
First adult patient with fibrosing colonopathy.
Am J Gastroenterol. 1998 Jul;93(7):1171-2. doi: 10.1111/j.1572-0241.1998.00355.x.
5
Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation.
Arch Dis Child. 1998 Apr;78(4):377-8. doi: 10.1136/adc.78.4.377.
6
Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-control study.
Gastroenterology. 1998 Mar;114(3):609-11; discussion 611-2. doi: 10.1016/s0016-5085(98)70549-9.
7
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):80-4. doi: 10.1097/00005176-199801000-00014.
8
Ultrasound studies of the intestinal wall in patients with cystic fibrosis.
J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):317-20. doi: 10.1097/00005176-199709000-00014.
9
Is fibrosing colonopathy an immune mediated disease?
Arch Dis Child. 1997 Jul;77(1):66-70. doi: 10.1136/adc.77.1.66.
10
Benign cystic teratoma simulating organized empyema.
Pediatr Pulmonol. 1997 Apr;23(4):310-3. doi: 10.1002/(sici)1099-0496(199704)23:4<310::aid-ppul9>3.0.co;2-p.
Zotero 插件